Anti-HYOU1/ GRP-170/ Grp170 functional antibody

Anti-HYOU1/ GRP-170/ Grp170 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to HYOU1/HYOU1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0274-Ab-1/ GM-Tg-hg-SE0274-Ab-2Anti-Human HYOU1 monoclonal antibodyHuman
GM-Tg-rg-SE0274-Ab-1/ GM-Tg-rg-SE0274-Ab-2Anti-Rat HYOU1 monoclonal antibodyRat
GM-Tg-mg-SE0274-Ab-1/ GM-Tg-mg-SE0274-Ab-2Anti-Mouse HYOU1 monoclonal antibodyMouse
GM-Tg-cynog-SE0274-Ab-1/ GM-Tg-cynog-SE0274-Ab-2Anti-Cynomolgus/ Rhesus macaque HYOU1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0274-Ab-1/ GM-Tg-felg-SE0274-Ab-2Anti-Feline HYOU1 monoclonal antibodyFeline
GM-Tg-cang-SE0274-Ab-1/ GM-Tg-cang-SE0274-Ab-2Anti-Canine HYOU1 monoclonal antibodyCanine
GM-Tg-bovg-SE0274-Ab-1/ GM-Tg-bovg-SE0274-Ab-2Anti-Bovine HYOU1 monoclonal antibodyBovine
GM-Tg-equg-SE0274-Ab-1/ GM-Tg-equg-SE0274-Ab-2Anti-Equine HYOU1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0274-Ab-1/ GM-Tg-hg-SE0274-Ab-2; GM-Tg-rg-SE0274-Ab-1/ GM-Tg-rg-SE0274-Ab-2;
GM-Tg-mg-SE0274-Ab-1/ GM-Tg-mg-SE0274-Ab-2; GM-Tg-cynog-SE0274-Ab-1/ GM-Tg-cynog-SE0274-Ab-2;
GM-Tg-felg-SE0274-Ab-1/ GM-Tg-felg-SE0274-Ab-2; GM-Tg-cang-SE0274-Ab-1/ GM-Tg-cang-SE0274-Ab-2;
GM-Tg-bovg-SE0274-Ab-1/ GM-Tg-bovg-SE0274-Ab-2; GM-Tg-equg-SE0274-Ab-1/ GM-Tg-equg-SE0274-Ab-2
Products NameAnti-HYOU1 monoclonal antibody
Formatmab
Target NameHYOU1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-HYOU1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0274-Ag-1Recombinant multi-species HYOU1/ GRP-170/ Grp170 protein


    Target information

    Target IDGM-SE0274
    Target NameHYOU1
    Gene ID10525,12282,192235,707715,479410,101094621,282295,100071323
    Gene Symbol and SynonymsCab140,CBP-140,GRP-170,Grp170,HSP12A,HYOU1,IMD59,ORP-150,ORP150
    Uniprot AccessionQ9Y4L1,Q63617
    Uniprot Entry NameHYOU1_HUMAN,HYOU1_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000149428
    Target ClassificationN/A

    The target: HYOU1, gene name: HYOU1, also named as GRP-170, Grp170, HSP12A, ORP-150, ORP150. The protein encoded by this gene belongs to the heat shock protein 70 family. This gene uses alternative transcription start sites. A cis-acting segment found in the 5' UTR is involved in stress-dependent induction, resulting in the accumulation of this protein in the endoplasmic reticulum (ER) under hypoxic conditions. The protein encoded by this gene is thought to play an important role in protein folding and secretion in the ER. Since suppression of the protein is associated with accelerated apoptosis, it is also suggested to have an important cytoprotective role in hypoxia-induced cellular perturbation. This protein has been shown to be up-regulated in tumors, especially in breast tumors, and thus it is associated with tumor invasiveness. This gene also has an alternative translation initiation site, resulting in a protein that lacks the N-terminal signal peptide. This signal peptide-lacking protein, which is only 3 amino acids shorter than the mature protein in the ER, is thought to have a housekeeping function in the cytosol. In rat, this protein localizes to both the ER by a carboxy-terminal peptide sequence and to mitochondria by an amino-terminal targeting signal. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.